Literature DB >> 3171594

Magnetic resonance imaging and clinical correlations in multiple sclerosis.

S J Huber1, G W Paulson, D Chakeres, A Pakalnis, M Brogan, B L Phillips, M A Myers, K W Rammohan.   

Abstract

We examined the relationship between magnetic resonance imaging (MRI) cerebral findings and clinical evaluations in 66 patients with clinically definite multiple sclerosis (MS). MRI observations included total number and location of lesions visualized, degree of periventricular involvement, degree of degeneration of the corpus callosum, and extent of generalized parenchymal atrophy. Overall physical disability was evaluated by the Kurtzke Expanded Disability Status Scale (EDSS) and individual symptoms were rated according to the Kurtzke Functional Systems (FS) scale. Our results suggest that MRI brain abnormalities are significantly related to the overall severity of disease, but MRI is not particularly useful to predict the presence or absence of individual symptoms. These findings do suggest that the MRI may provide useful information to monitor clinical progression of patients with MS, but the lesions visualized need not always be symptomatic nor are we sure that all symptomatic lesions, particularly in the spinal cord and optic nerves, will be visualized.

Entities:  

Mesh:

Year:  1988        PMID: 3171594     DOI: 10.1016/0022-510x(88)90002-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Metabolic disturbances in the gray matter of the human brain in autoimmune demyelinating disease of the nervous system and their contribution to the symptomatology of the disease.

Authors:  L N Prakhova; A G Il'ves; G V Kataeva; M S Rudas; N A Totolyan; I D Stolyarov
Journal:  Dokl Biol Sci       Date:  2002 Sep-Oct

Review 2.  Immunotherapy for multiple sclerosis.

Authors:  R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

3.  The role of qualitative and quantitative MRI assessment of multiple sclerosis lesions according to their in evaluating the efficacy of intravenous immunoglobulin G.

Authors:  B Koçer; S Yildirim-Gürel; E T Tali; C Irkeç; S Işik
Journal:  Neuroradiology       Date:  2004-03-04       Impact factor: 2.804

4.  A pain-mediated neural signal induces relapse in murine autoimmune encephalomyelitis, a multiple sclerosis model.

Authors:  Yasunobu Arima; Daisuke Kamimura; Toru Atsumi; Masaya Harada; Tadafumi Kawamoto; Naoki Nishikawa; Andrea Stofkova; Takuto Ohki; Kotaro Higuchi; Yuji Morimoto; Peter Wieghofer; Yuka Okada; Yuki Mori; Saburo Sakoda; Shizuya Saika; Yoshichika Yoshioka; Issei Komuro; Toshihide Yamashita; Toshio Hirano; Marco Prinz; Masaaki Murakami
Journal:  Elife       Date:  2015-08-11       Impact factor: 8.140

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.